Reuters Health News Summary
Following is a summary of current health news briefs.
Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk
Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S.
prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors. The hikes come as drugmakers are reeling from effects of the COVID-19 pandemic, which has reduced doctor visits and demand for some drugs.
They are also fighting new drug price cutting rules from the Trump administration, which would reduce the industry's profitability.
Fauci sees U.S. gaining control over pandemic by next autumn
The leading U.S. infectious disease specialist, Dr.
Anthony Fauci, said on Wednesday he foresees America achieving enough collective COVID-19 immunity through vaccinations to regain "some semblance of normality" by autumn 2021, despite early setbacks in the vaccine rollout. Fauci made his remarks during an online discussion of the pandemic with California Governor Gavin Newsom, who announced at the outset that a more infectious coronavirus variant originally found in Britain has been detected in his state, a day after the first known U.S.
case was documented in Colorado.
New York City aims to vaccinate 1 million against COVID-19 by end of January
New York City aims to vaccinate 1 million residents against the coronavirus by the end of January 2021, Mayor Bill de Blasio said on Thursday.
He said the effort will require setting up vaccination sites across the city, which is home to about 8.3 million people.
China gives its first COVID-19 vaccine approval to Sinopharm
China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter.
No detailed efficacy data of the vaccine has been publicly released but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said on Wednesday its vaccine was 79.34% effective in preventing people from developing the disease based on interim data.
vaccinations in 2020 fall far short of target of 20 million people
Only about 2.8 million Americans had received a COVID-19 vaccine going into the last day of December, putting the United States far short of the government's target to vaccinate 20 million people this month.
Shots are reaching nursing home residents at an even slower pace than others first in line even though they are most at risk of dying of the virus.
British family doctors criticize change of plan on vaccine boosters
LONDON (Reuters) - British doctors have said a government decision to delay giving a coronavirus vaccine booster shot to vulnerable patients who have already had a first dose will be distressing and disruptive, their trade union said on Thursday.
The government said on Wednesday it wanted to give a first dose to as many people as possible before starting to administer boosters at 12 weeks, in an effort to provide more people with a degree of protection more quickly.
Brazil detects two cases of new coronavirus variant found in UK
A Brazilian lab said on Thursday it has detected two cases of the new coronavirus variant that has spread rapidly in Britain, du lịch bắc kinh and bắc kinh urged reinforcement of quarantine measures for travelers coming from Europe.
Diagnostic medicine company Dasa said in a statement that it had detected the SARS-CoV-2 strain B.1.1.7 through genetic sequencing done in partnership with Sao Paulo University's Tropical Medicine Institute.
China reports first case of new coronavirus variant - CDC publication
China has detected its first imported case of the new coronavirus variant that is spreading rapidly around Britain, according to a publication run by the Chinese Center for Disease Control and Prevention (CDC).
Countries around the world have cut off travel links to Britain to stop the spread of the new variant, bắc kinh which scientists have said is 40-70% more transmissible than the original virus.
Local funding crisis threatens U.S. vaccine rollout
Seattle public health officials have so little COVID-19 funding on hand they worry they will have to shut down some virus testing sites as they mount a campaign to dose their 2.3 million residents with Pfizer Inc's and Moderna Inc's vaccines.
King County, which represents greater Seattle, has $14 million of COVID-19 funding for 2021, roughly what it spends in a month to run public testing sites and other services, and a fraction of the $87 million emergency COVID-19 aid it received in 2020, said Ingrid Ulrey, the public health policy director for King County.
What you need to know about the coronavirus right now
Here's what you need to know about the coronavirus right now: Fauci sees U.S.
gaining control by next autumn